ArticleBioengineered2026
Statement of retraction: Ginsenoside Rg3 and sorafenib combination therapy relieves the hepatocellular carcinomaprogression through regulating the HK2-mediated glycolysis and PI3K/Akt signaling pathway.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.